摘要
目的 探讨小梁切除联合丝裂霉素C和巩膜可调缝线治疗新生血管性青光眼的疗效。方法 对 11例 15眼确诊为新生血管性青光眼患者行小梁切除 ,联合丝裂霉素C和巩膜可调缝线 ,术中为预防虹膜根部切除时发生出血应用肾上腺素。结果 随访观察 1～ 8个月 ,平均 5 .7个月 ,2例视力有不同程度的提高 ,8例保持不变 ,1例下降。 7例 11眼术后眼压控制在正常范围 ,其成功率 6 3.6 4 % .术后 2个月虹膜新生血管全部消退者 2例 ;5例虹膜表面新生血管变淡或大部分消退 ,其余无明显改变。 1例 1眼术中前房出血 ,术后 7d自行吸收 ,4例 4眼术后眼压需药物控制。结论 小梁切除联合丝裂霉素C和巩膜可调缝线是治疗新生血管性青光眼安全有效的方法之一。
Objective To study the effect of the treatment of neovasculer glaucoma by the joint use of trabeculectomy,mitomycin C and adjustable scleral raphe.Methods Through the joint use of trabeculectomy,mitomycin C and adjustable scleral raphe,we had operated 11 cases(15eyes)dignosed as neovascular glaucoma.In the operation,we used adrenalin to prevent iris root from bleeding during the trabeculectomy. Results After the operation 7 cases(11 eyes)of intraocular pressure were controlled.Within the normal range,and two months after the operation,all iris neovascular disappeared.one case(1 eye)of anterior chamber bleeding during operations,after 7 days,automatically absorbed.One cases (1 eye)of intraocular pressure had to be controlled by medicine.Conclusion The joint use of trabeculectomy,mitomycin C and adjustable scleral raphe is one of the safe and effective methods to treat the neovascular glaucoma.
出处
《眼科新进展》
CAS
2004年第4期293-294,共2页
Recent Advances in Ophthalmology
